- July 30, 2026☀️ Our latest Summer Newsletter is here! Catch up on the latest Amyloidosis Foundation news, upcoming events, and ways you…
- July 23, 2026– Of first 20 patients, all four MRD-negative patients have converted to complete response (CR) – – CR rate now…
- June 16, 2026NAPLES, Fla., June 4, 2026— Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with…
- June 16, 2026– Of first 20 patients, all four MRD-negative patients have converted to complete response (CR) – – CR rate now…
- May 29, 2026PUBLISHED 29 May 2026 AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and…
- April 30, 2026Be sure to catch up on the latest happenings in our spring newsletter here!
January 15, 2026Be sure to catch up on the latest happenings in our winter newsletter here!- January 6, 2026Each year, landmarks, homes, and communities across the country light up in red to honor those affected by amyloidosis and…
November 12, 2025JAMA Cardiol Published Online: November 8, 2025 Today at the AHA congress in New Orleans, BridgeBio presented data showing that acoramidis significantly reduces…- May 21, 2025Be sure to catch up on the latest happenings in our fall newsletter here!
7151 N. Main St. Ste. 2 Clarkston, MI 48346
248-922-9610